$PHR Income Statement | Understand Stock

$PHR

$12.50 -$0.11 (0.87%) Live

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to Jan 31, 2026	FY2025 12 months to Jan 31, 2025	FY2024 12 months to Jan 31, 2024	FY2023 12 months to Jan 31, 2023	FY2022 12 months to Jan 31, 2022
Revenues
Subscription and related services
Payment processing fees
Life sciences
Payment solutions
Network solutions
Total revenues

Expenses:
Cost of revenue (excluding depreciation and amortization)
Payment solutions expense
Sales and marketing
Research and development
General and administrative
Depreciation
Amortization
Total expenses
Operating loss
Other income, net
Change in fair value of warrant liability
Loss on extinguishment of debt
Interest income, net
Interest expense
Interest income
Total interest income, net
Total other (expense) income, net
Loss before income tax expense
Income tax benefit (expense)
Net income (loss)
Preferred stock dividends paid
Accretion of redeemable preferred stock
Net loss attributable to common stockholders, basic
Net loss attributable to common stockholders, diluted
Net income (loss) per share attributable to common stockholders - basic (in dollars per share)
Net income (loss) per share attributable to common stockholders - diluted (in dollars per share)
Weighted-average common shares outstanding - basic (in shares)
Weighted-average common shares outstanding - diluted (in shares)

Comments